Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Evommune director Arthur S. Kirsch executed a $133,000 purchase of 10,000 shares on July 7, 2026. The transaction occurred as the stock traded near its 52-week low, despite recent analyst downgrades triggered by a failed Phase 2b clinical trial for EVO756 in chronic spontaneous urticaria. Kirsch holds the shares through a family trust where he serv…
William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (NASDAQ:CORT), executed the sale of 20,000 shares of the company's common stock on July 7, 2026, generating approximately $1.86 million in proceeds. The transaction was facilitated through a pre-arranged 10b5-1 trading plan adopted on November 27, 2024. This sale coincides with CO…
Javier Olivan, Chief Operating Officer of Meta Platforms, Inc. (NASDAQ:META), executed a sale of Class A Common Stock valued at approximately $3.15 million on July 6, 2026. The transaction involved the liquidation of 5,235 shares across direct and indirect holdings, adhering to a Rule 10b5-1 trading plan established in late 2025. This executive act…
Atay Oguzhan, Chairman and CEO of BillionToOne Inc. (NASDAQ:BLLN), executed significant transactions involving the company's Class A Common Stock on July 6, 2026, under a Rule 10b5-1 trading plan. The transactions included the sale of approximately $4.7 million in shares and the acquisition of 26,250 shares through the exercise of vested stock opti…
Michael L Speiser, a director at Snowflake Inc. (NASDAQ: SNOW), executed a significant divestment of company equity on July 6, 2026, selling approximately $12.2 million worth of shares. The transaction was facilitated through a pre-arranged 10b5-1 trading plan established in late 2024, ensuring compliance with regulatory frameworks for insider trad…
Michael L. Speiser, a director at Snowflake Inc., executed a sale of common stock totaling approximately $216,641 on July 6, 2026. The transaction involved 840 shares sold via an indirect holding through a trust, following a pre-arranged 10b5-1 trading plan established in late 2024. This sale occurred as Snowflake's stock traded near its 52-week hi…
Michael L Speiser, a director at Snowflake Inc. (SNOW), executed a sale of common stock totaling $649,925 on July 6, 2026. The transaction involved shares held indirectly through trusts where Mr. Speiser serves as trustee, adhering to a pre-arranged 10b5-1 trading plan established in December 2024. Following the sale, Mr. Speiser retains indirect o…
Arvind Nithrakashyap, Chief Technology Officer at Rubrik, Inc., executed a series of sales totaling 38,460 shares of Class A Common Stock between July 6 and July 8, 2026. The transactions, valued at approximately $3.33 million, were conducted under a Rule 10b5-1 trading plan established in October 2025. This activity occurs as Rubrik reports financ…
Robert Baltera Jr., a director at Palisade Bio, Inc. (NASDAQ: PALI), has acquired an additional $102,084 worth of the company's common stock through two separate transactions in early July 2026. This insider buying activity occurs as Palisade Bio advances its clinical pipeline, having recently secured FDA clearance for an Investigational New Drug a…
Palisade Bio, Inc. (NASDAQ: PALI) reported significant insider activity as Chief Medical Officer Mitchell Lawrence Jones executed a stock sale on July 7, 2026. The transaction was necessitated by tax withholding requirements following the vesting of Restricted Stock Units (RSUs). This financial maneuver occurs against a backdrop of clinical progres…
AppLovin Corp (NASDAQ: APP) Director Maynard G. Webb Jr. executed a sale of 3,076 shares of the company's Class A Common Stock on July 6, 2026. The transaction, valued at $1,603,489, was conducted at prices ranging from $516.25 to $524.12 per share. Webb's sale was facilitated through a Rule 10b5-1 trading plan established on March 3, 2026, a mecha…
Palisade Bio, Inc. (NASDAQ: PALI) has seen significant insider activity as Chief Executive Officer and Chief Financial Officer John David Finley executed a substantial sale of company shares. The transaction, valued at approximately $303,343, was primarily driven by the need to cover tax withholding obligations related to the vesting of restricted …
Contineum Therapeutics, Inc. (NASDAQ: CTNM) CEO Carmine N. Stengone executed a $40,000 share sale on July 8, 2026, following the exercise of 2,500 stock options at $1.01 per share. The transaction, facilitated by a 10b5-1 plan adopted in September 2025, occurred as CTNM shares traded near their 52-week high of $16.91, reflecting a 299% annual retur…
OAS Energy LLC, acting as both an insider and Chief Artificial Intelligence Officer of Cuentas Inc. (NASDAQ: CUEN), executed a share acquisition on July 7, 2026, according to a Securities and Exchange Commission filing. The transaction involved 2,500 shares purchased at $0.443 each, bringing the entity's total direct holdings to 107,721 shares.
AJB Investment Fund II, LP, along with affiliated entities and individuals Adam J. Bradley and Melinda Bradley, have increased their stake in Jewett-Cameron Trading Co Ltd (NASDAQ:JCTC) through recent open market purchases. The transactions, totaling $86,410, occurred on July 7 and July 8, 2026, with share prices ranging from $2.485 to $2.5199. Thi…
Brady Brewer, serving as the Chief Executive Officer for International operations at Starbucks Corp. (NASDAQ: SBUX), completed the sale of company common stock valued at $231,816 on July 6, 2026. The transaction involved the disposal of 2,229 shares at a price of $104.00 per share, executed under a Rule 10b5-1 trading plan established by Brewer on …
ZipRecruiter, Inc. (NASDAQ:ZIP) Chief Executive Officer Ian H. Siegel has completed the sale of $115,191 in company shares through a pre-arranged trading plan. The transaction occurs as the company manages significant debt repurchases, expands its technological capabilities with AI integrations, and undergoes routine corporate governance updates.
Rush Street Interactive's Chief Financial Officer, Kyle Sauers, completed a share transaction totaling $725,190 on July 6, 2026. The sale was executed under a pre-arranged 10b5-1 trading plan involving 23,000 shares at $31.53 each. This activity takes place as RSI stock trades near its 52-week high of $32.86, following a 112% gain over the past yea…
Block, Inc. (NYSE: SQ) director Anthony Mathew Eisen executed a series of stock sales totaling approximately $1.41 million over three consecutive days in early July 2026. The transactions, conducted under a Rule 10b5-1 trading plan established in March, represent a portion of his holdings. Despite the insider selling, the company continues to see s…
Sezzle Inc. (NASDAQ: SEZL) Chief Financial Officer Brading Lee Dickson executed a sale of 100 shares on July 6, 2026, under a pre-existing trading plan. The transaction occurred as the company's stock reached its 52-week high, prompting mixed analyst reactions and heightened market scrutiny regarding valuation and legal developments.
Todd Krasnow, a director at Symbotic Inc. (NASDAQ: SYM), has executed a series of transactions to sell over 5,300 shares of the company's Class A Common Stock between May and July 2026. The sales, totaling approximately $259,565, occurred across two distinct phases: a direct disposal in May and a redemption followed by a sale in July under a pre-ar…
Stitch Fix Inc. (NASDAQ: SFIX) Chief Financial Officer David Aufderhaar completed a significant share sale on July 6, 2026, disposing of 67,960 Class A Common Stock shares. The transaction, valued at $257,432, was executed under a Rule 10b5-1 trading plan established in January 2026. This move occurs against a backdrop of recent company earnings th…
Anthony Bacos, Stitch Fix's Chief Product and Technology Officer, executed a series of transactions on July 6, 2026, selling 70,000 shares of Class A Common Stock valued at $265,089. These sales were conducted under a Rule 10b5-1 trading plan established in March 2026. The transactions occurred against a backdrop of recent financial results that be…
Michael Wittmann, Chief Operating Officer at indie Semiconductor, Inc. (NASDAQ: INDI), executed a transaction involving the sale of 6,250 shares of the company's Class A Common Stock on July 6, 2026. The transaction, valued at $29,213, was conducted through a Rule 10b5-1 trading plan, which is typically utilized for automated sales to satisfy tax o…
Gary Friedman, Chairman and CEO of RH (NYSE: RH), executed a series of stock sales totaling approximately $20.6 million between July 6 and July 8, 2026. These transactions, involving 129,200 shares, were conducted across multiple price points ranging from $154.70 to $171.10, reflecting a strategic approach to portfolio diversification. Despite the …
